Tarsus Pharmaceuticals (TARS) Total Assets (Quarterly): 505.50M

Tarsus Pharmaceuticals, Inc. (TARS)

80.28 +3.39 (+4.41%) USD | NASDAQ | Nov 13, 16:00

80.40 +0.12 (+0.15%) After-Hours: 19:59

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.

Date	Value
September 30, 2026	505.50M
June 30, 2026	611.14M
March 31, 2026	581.14M
December 31, 2025	566.90M
September 30, 2025	534.56M
June 30, 2025	494.99M
March 31, 2025	500.75M
December 31, 2024	377.34M
September 30, 2024	376.30M
June 30, 2024	376.84M
March 31, 2024	349.28M
December 31, 2023	266.22M
September 30, 2023	268.33M
June 30, 2023	188.93M

Date	Value
March 31, 2023	211.21M
December 31, 2022	227.86M
September 30, 2022	236.46M
June 30, 2022	252.83M
March 31, 2022	181.48M
December 31, 2021	178.91M
September 30, 2021	190.41M
June 30, 2021	203.45M
March 31, 2021	193.95M
December 31, 2020	171.97M
September 30, 2020	92.18M
June 30, 2020	56.24M
March 31, 2020
December 31, 2019	58.32M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks